<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Genet</journal-id>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32391058</article-id>
<article-id pub-id-type="pmc">7193025</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2020.00385</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Integrating Genome-Wide Association Studies and Gene Expression Profiles With Chemical-Genes Interaction Networks to Identify Chemicals Associated With Colorectal Cancer</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tan</surname>
<given-names>Xinyue</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/772438/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tang</surname>
<given-names>Hanmin</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gong</surname>
<given-names>Liuyun</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/913247/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xie</surname>
<given-names>Lina</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lei</surname>
<given-names>Yutiantian</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>Zhenzhen</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Chenchen</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ma</surname>
<given-names>Jinlu</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/654887/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Han</surname>
<given-names>Suxia</given-names>
</name>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/774747/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff><institution>Department of Oncology, The First Affiliated Hospital, Xi’an Jiaotong University</institution>, <addr-line>Xi’an</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Ryan Matthew Layer, University of Colorado Boulder, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Shihao Shen, University of California, Los Angeles, United States; Lei Zhang, Soochow University, China</p>
</fn>
<corresp id="c001">*Correspondence: Suxia Han, <email>shan87@mail.xjtu.edu.cn</email></corresp>
<fn fn-type="other" id="fn004">
<p>This article was submitted to Bioinformatics and Computational Biology, a section of the journal Frontiers in Genetics</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>4</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>11</volume>
<elocation-id>385</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>7</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>3</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Tan, Tang, Gong, Xie, Lei, Luo, He, Ma and Han.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Tan, Tang, Gong, Xie, Lei, Luo, He, Ma and Han</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Colorectal cancer (CRC) is the third most common cancer and has the second highest mortality rate in global cancer. Exploring the associations between chemicals and CRC has great significance in prophylaxis and therapy of tumor diseases. This study aims to explore the relationships between CRC and environmental chemicals on genetic basis by bioinformatics analysis. The genome-wide association study (GWAS) datasets for CRC were obtained from the UK Biobank. The GWAS data for colon cancer (category C18) includes 2,581 individuals and 449,683 controls, while that of rectal cancer (category C20) includes 1,244 individuals and 451,020 controls. In addition, we derived CRC gene expression datasets from the NCBI-GEO (GSE106582). The chemicals related gene sets were acquired from the comparative toxicogenomics database (CTD). Transcriptome-wide association study (TWAS) analysis was applied to CRC GWAS summary data and calculated the expression association testing statistics by FUSION software. We performed chemicals related gene set enrichment analysis (GSEA) by integrating GWAS summary data, mRNA expression profiles of CRC and the CTD chemical-gene interaction networks to identify relationships between chemicals and genes of CRC. We observed several significant correlations between chemicals and CRC. Meanwhile, we also detected 5 common chemicals between colon and rectal cancer, including methylnitronitrosoguanidine, isoniazid, PD 0325901, sulindac sulfide, and importazole. Our study performed TWAS and GSEA analysis, linked prior knowledge to newly generated data and thereby helped identifying chemicals related to tumor genes, which provides new clues for revealing the associations between environmental chemicals and cancer.</p>
</abstract>
<kwd-group>
<kwd>colorectal cancer</kwd>
<kwd>genome-wide association study</kwd>
<kwd>transcriptome-wide association study</kwd>
<kwd>gene set enrichment analysis</kwd>
<kwd>comparative toxicogenomics database</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="3"></table-count>
<equation-count count="2"></equation-count>
<ref-count count="67"></ref-count>
<page-count count="9"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S1">
<title>Introduction</title>
<p>Colorectal cancer (CRC) is the third most common cancer worldwide and has the second highest mortality rate in global cancer (<xref ref-type="bibr" rid="B6">Bray et al., 2018</xref>; <xref ref-type="bibr" rid="B14">Ferlay et al., 2019</xref>). In western countries, CRC accounts for about 10% of cancer deaths (<xref ref-type="bibr" rid="B32">Kuipers et al., 2015</xref>). The accepted view is that genetic, lifestyle, and environmental factors are closely related to CRC (<xref ref-type="bibr" rid="B12">Dekker et al., 2019</xref>). Current research shows that environmental chemicals play important roles in the etiology of CRC. Several chemicals have been suggested to promote the tumorigenesis and development of CRC. For instance, analysis of an Iowa Women’s Health Study cohort suggested that exposure to TTHM in drinking water is associated with increased risk of rectal cancer (<xref ref-type="bibr" rid="B29">Jones et al., 2019</xref>). In addition, another case-control study observed that organochlorine and organophosphorus pesticides may induce CRC (<xref ref-type="bibr" rid="B1">Abolhassani et al., 2019</xref>). In contrast, numerous chemicals have been identified that inhibit CRC. Metastatic CRC (mCRC) often indicates a poor prognosis. The 5-year overall survival (OS) rate of patients with mCRC is less than 15% (<xref ref-type="bibr" rid="B51">Siegel et al., 2017</xref>; <xref ref-type="bibr" rid="B6">Bray et al., 2018</xref>), and the median OS of unresectable mCRC patients who received only supportive therapy was only 5 months (<xref ref-type="bibr" rid="B38">Lucas et al., 2011</xref>). However, the 5-years OS rate increased to 10% in such patients receiving 5-fluorouracil (5-FU)/leucovorin (LV) plus oxaliplatin (FOLFOX) (<xref ref-type="bibr" rid="B22">Gustavsson et al., 2015</xref>). Thus, FOLFOX chemotherapy regimen is still the standard first-line therapy for unresectable mCRC (<xref ref-type="bibr" rid="B16">Giacchetti et al., 2000</xref>; <xref ref-type="bibr" rid="B17">Goldberg et al., 2004</xref>; <xref ref-type="bibr" rid="B31">Kouhara et al., 2007</xref>; <xref ref-type="bibr" rid="B5">Bokemeyer et al., 2011</xref>). Recent studies have found that some non-chemotherapeutic chemicals also have an inhibitory effect on CRC, such as semisynthetic retinoid, lidocaine, and beta-carotene (<xref ref-type="bibr" rid="B41">Mattingly et al., 2003</xref>; <xref ref-type="bibr" rid="B45">Pham et al., 2013</xref>; <xref ref-type="bibr" rid="B47">Qu et al., 2018</xref>).</p>
<p>Therefore, it has great significance to clarify the relationship between chemicals in environmental and CRC for the treatment and prevention of diseases. But obtaining the entire life-time exposure of an individual is difficult and complex, for lacking sensitive methods to measure specific exposures. Although the exposure is known to have occurred, the transient character of the exposure indicators increases the difficulty of measuring the specific exposure (<xref ref-type="bibr" rid="B43">Messerlian et al., 2017</xref>). With the help of new technologies, such as genome-wide association research (GWAS), more convenient and efficient analyses have been produced to identify interactions between multiple environmental exposures with genes (<xref ref-type="bibr" rid="B30">Khoury et al., 2005</xref>). Studies of gene-environment interactions have been widely applied in psychological research, however, lack in the field of oncology (<xref ref-type="bibr" rid="B40">Manuck and McCaffery, 2014</xref>). The Comparative Toxicogenomics Database (CTD) is a public repository, aims to advance people’s understanding of how environmental exposures affects human health (<xref ref-type="bibr" rid="B41">Mattingly et al., 2003</xref>). This database provides information regarding chemical-gene/protein interactions as well as chemical- and gene-disease relationships that is organized by individual genes, gene sets, organisms, chemicals, sequence type (DNA, mRNA, and protein), gene ontology annotations and sequences (<xref ref-type="bibr" rid="B42">Mattingly et al., 2006</xref>).</p>
<p>Genome-wide association studies (GWAS) analyze DNA sequence variations to provide associations for complex human traits and diseases efficiently (<xref ref-type="bibr" rid="B54">Tam et al., 2019</xref>). Transcriptome-wide association studies (TWAS) is further developed on this basis, which can evaluate the association of each gene to diseases by integrating tissue-related gene expression measurements with GWAS summary data (<xref ref-type="bibr" rid="B18">Gong et al., 2018</xref>). Currently, TWAS has been proved with high efficiency in determining the genetic mechanism of complex diseases (<xref ref-type="bibr" rid="B21">Gusev et al., 2018</xref>; <xref ref-type="bibr" rid="B61">Wu et al., 2018</xref>). The Gene Expression Omnibus (GEO) is a worldwide resource which distributes a large number of high-throughput microarray and next-generation sequence functional genomic data sets (<xref ref-type="bibr" rid="B3">Barrett et al., 2013</xref>). Different from the traditional GWAS to explain the relationship between DNA and external phenotype, we simultaneously used the GEO to obtain the gene expression profile (mRNA expression profile chip data) of colorectal cancer, that is, a comprehensive analysis at the DNA and mRNA level. This is helpful to narrow the range of chemicals related candidate genes on the basis of traditional GWAS analysis.</p>
<p>Briefly, in this work, the CTD chemical-gene interaction networks, GWAS summary datasets and gene expression profiles were integrated. TWAS analysis was performed by FUSION software to evaluate the expression association testing statistics. The gene set enrichment analysis (GSEA) with the running-sum statistic and weighted Kolmogorov-Smirnov–like statistic were applied to detect the correlation between environmental chemicals and CRC (<xref ref-type="bibr" rid="B9">Charmpi and Ycart, 2015</xref>). Firstly, we obtained the empirical distributions of GSEA statistics for each chemical for statistical tests. Subsequently, the <italic>P-</italic>value of each chemical was conducted from the permuted empirical distribution of GSEA statistics. Finally, we summarized and analyzed the obtained chemicals associated with CRC.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="S2.SS1">
<title>GWAS Summary Dataset for CRC</title>
<p>GeneATLAS<sup><xref ref-type="fn" rid="footnote1">1</xref></sup>, a huge resource storing the information of hundreds of traits and millions of related gene variants based on the UK Biobank cohort, provides a convenient way for researchers to acquire data from the UK Biobank (<xref ref-type="bibr" rid="B37">Lin et al., 2019</xref>). To be specific, it allows researchers to query genome-wide association results for 9,113,133 genetic variants and download over 30 million genetic variants (&gt;23 billion phenotype-genotype pairs) for GWAS summary statistics (<xref ref-type="bibr" rid="B7">Canela-Xandri et al., 2018</xref>).</p>
<p>A large-scale GWAS summary data of colon cancer and rectal cancer in our study were downloaded from the GeneATLAS in UK Biobank. In the cancer register category, 103,470 data items are available from 84,726 participants. In brief, our GWAS summary data, which contained 5,899 available data items, were from categories C18 (malignant neoplasm of colon) and C20 (malignant neoplasm of rectum). Detailed information regarding the methods, process, and approaches were described in the previous studies (<xref ref-type="bibr" rid="B24">Hammerschlag et al., 2017</xref>).</p>
</sec>
<sec id="S2.SS2">
<title>Gene Expression Datasets of CRC</title>
<p>NCBI-GEO<sup><xref ref-type="fn" rid="footnote2">2</xref></sup> is an international public repository with next-generation sequencing and microarray/gene profiles which was used in this study to obtain the mRNA expression profiles of mucosa and colorectal tumor tissues (GSE106582). CRC patients were recruited at the University Hospital of Heidelberg, from whom the gene expression profiles of 77 tumor and 117 mucosa tissues were obtained using an Illumina HumanHT-12 V4.0 expression beadchip. Using GEO2R, a web tool based on the GEO database, differential gene expression was assessed by comparing the expression of genes from colorectal tumor tissues to those of respective mucosa tissues.</p>
</sec>
<sec id="S2.SS3">
<title>Transcriptome-Wide Association Study (TWAS) Methodology</title>
<p>TWAS analysis utilizes disease GWAS summary statistics combining with pre-computed gene expression weights to calculate the association of every gene with known diseases (<xref ref-type="bibr" rid="B21">Gusev et al., 2018</xref>). In other words, TWAS can integrate the associations between GWAS and gene expression measurements to identify genes associated with traits. In this study, A TWAS for CRC was conducted using functional summary-based imputation (FUSION) software and the gene expression weight references of whole blood, rectum, and colon tissues were acquired from the FUSION website<sup><xref ref-type="fn" rid="footnote3">3</xref></sup>. Specifically, the gene expression weights of whole blood were collected from 1,264 subjects of the Young Finns Study (<xref ref-type="bibr" rid="B48">Raitakari et al., 2008</xref>; <xref ref-type="bibr" rid="B44">Nuotio et al., 2014</xref>).</p>
<p>Firstly, based on FUSION software we performed prediction models to calculate the gene expression weights of different tissues (<xref ref-type="bibr" rid="B27">Huang et al., 2019</xref>). Then we conducted the correlation statistics between gene expressed level and CRC combining the gene expression weights and summary-level GWAS results. Z<sub><italic>TWAS</italic></sub> = w’Z/(w’Lw)<sup>1/2</sup> was used to calculate the association statistics. Z denotes the scores of CRC while w denotes the weights. L means the SNP-correlation linkage disequilibrium (LD) matrix. A TWAS <italic>p-</italic>value was calculated for each gene within whole blood, rectum and colon tissues, respectively (<xref ref-type="bibr" rid="B46">Qi et al., 2019</xref>). The genes with <italic>p</italic> &lt; 0.05 were considered as significant. Detailed information can be found in the published study (<xref ref-type="bibr" rid="B21">Gusev et al., 2018</xref>).</p>
</sec>
<sec id="S2.SS4">
<title>Chemical-Gene Expression Interaction Database of the CTD Database</title>
<p>The Comparative Toxicogenomics Database (CTD)<sup><xref ref-type="fn" rid="footnote4">4</xref></sup> is a publicly and accessible database for toxicogenomic information (<xref ref-type="bibr" rid="B66">Zhang et al., 2019</xref>). The CTD currently includes more than 30.5 million toxicogenomic relationships associated with chemicals, proteins, etc. (<xref ref-type="bibr" rid="B10">Davis et al., 2017</xref>) and provides information regarding chemical, gene, phenotype, and disease relationships to advance our understanding of the effects of environmental toxin exposure on public health (<xref ref-type="bibr" rid="B20">Grondin et al., 2018</xref>). A unique and powerful feature of the CTD is knowledge transfer with respect to any information that is directly annotated to chemicals, genes and diseases (<xref ref-type="bibr" rid="B11">Davis et al., 2013</xref>). This study download 11,190 chemicals related gene sets from the CTD. The process of retrieving information using CTD was described in the study previously (<xref ref-type="bibr" rid="B42">Mattingly et al., 2006</xref>).</p>
</sec>
<sec id="S2.SS5">
<title>Identification of Environmental Chemicals Elements Associated With Colorectal Cancer</title>
<p>The GSEA algorithm was originally used for microarray study and GWAS-based GSEA was developed subsequently (<xref ref-type="bibr" rid="B25">He et al., 2018</xref>). At present, it is utilized to identify abnormally expressed gene sets for target diseases, and has been applied in etiology researches of multiple diseases (<xref ref-type="bibr" rid="B58">Wang et al., 2007</xref>). Firstly, for the <italic>j</italic>th (j = 1,2,3…<italic>N</italic>) gene, the most significant GWAS association test statistics of the SNPs was assigned to <italic>j</italic>th gene according to the score r<sub>j</sub> of the given gene. Secondly, all genes G = (G<sub>1^*</sub>, G<sub>2*</sub>,…,G<sub><italic>N^*</italic></sub>) were ranked by their scores from the highest to the lowest (<xref ref-type="bibr" rid="B25">He et al., 2018</xref>), which was expressed as U = (j<sub>1^*</sub>, j<sub>2^*</sub>,…,j<sub><italic>N^*</italic></sub>). Thirdly, for a chemicals related gene set <italic>S</italic>, an enrichment score <italic>ES</italic> was calculated for CRC by the running sum statistic and weighted Kolmogorov-Smirnov-like statistic (<xref ref-type="bibr" rid="B53">Subramanian et al., 2005</xref>; <xref ref-type="bibr" rid="B9">Charmpi and Ycart, 2015</xref>). Gene set S independently derived from <italic>N</italic><sub><italic>H</italic></sub> genes. <italic>ES</italic> represents the overrepresentation of CRC associated genes in chemicals related gene set S. <italic>ES</italic> was calculated as:</p>
<disp-formula id="S2.Ex1">
<mml:math id="M1">
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mtext mathvariant="bold">ES</mml:mtext>
<mml:mo>⁢</mml:mo>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="bold">S</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo>=</mml:mo>
<mml:mrow>
<mml:munder>
<mml:mo mathvariant="bold" movablelimits="false">max</mml:mo>
<mml:mrow>
<mml:mn mathvariant="bold">1</mml:mn>
<mml:mo>≤</mml:mo>
<mml:mi mathvariant="bold">j</mml:mi>
<mml:mo>≤</mml:mo>
<mml:mi mathvariant="bold">N</mml:mi>
</mml:mrow>
</mml:munder>
<mml:mrow>
<mml:mo>{</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:munder>
<mml:mo largeop="true" movablelimits="false" symmetric="true">∑</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="bold">G</mml:mi>
<mml:msup>
<mml:mi mathvariant="bold">j</mml:mi>
<mml:mo>*</mml:mo>
</mml:msup>
</mml:msub>
<mml:mo>∈</mml:mo>
<mml:mi mathvariant="bold">S</mml:mi>
</mml:mrow>
<mml:mo>,</mml:mo>
<mml:mrow>
<mml:msup>
<mml:mi mathvariant="bold">j</mml:mi>
<mml:mo>*</mml:mo>
</mml:msup>
<mml:mo>≤</mml:mo>
<mml:mi mathvariant="bold">j</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:munder>
<mml:mfrac>
<mml:msup>
<mml:mrow>
<mml:mo stretchy="false">|</mml:mo>
<mml:msub>
<mml:mtext mathvariant="bold">r</mml:mtext>
<mml:msup>
<mml:mi mathvariant="bold">j</mml:mi>
<mml:mo>*</mml:mo>
</mml:msup>
</mml:msub>
<mml:mo stretchy="false">|</mml:mo>
</mml:mrow>
<mml:mi mathvariant="bold">p</mml:mi>
</mml:msup>
<mml:msub>
<mml:mtext mathvariant="bold">N</mml:mtext>
<mml:mi mathvariant="bold">R</mml:mi>
</mml:msub>
</mml:mfrac>
</mml:mrow>
<mml:mo>-</mml:mo>
<mml:mrow>
<mml:munder>
<mml:mo largeop="true" movablelimits="false" symmetric="true">∑</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="bold">G</mml:mi>
<mml:msup>
<mml:mi mathvariant="bold">j</mml:mi>
<mml:mo>*</mml:mo>
</mml:msup>
</mml:msub>
<mml:mo>∉</mml:mo>
<mml:mi mathvariant="bold">S</mml:mi>
</mml:mrow>
<mml:mo>,</mml:mo>
<mml:mrow>
<mml:msup>
<mml:mi mathvariant="bold">j</mml:mi>
<mml:mo>*</mml:mo>
</mml:msup>
<mml:mo>≤</mml:mo>
<mml:mi mathvariant="bold">j</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:munder>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:mtext mathvariant="bold">N</mml:mtext>
<mml:mo>-</mml:mo>
<mml:msub>
<mml:mtext mathvariant="bold">N</mml:mtext>
<mml:mi mathvariant="bold">H</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:mrow>
<mml:mo>}</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:mrow>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula>
<p>where</p>
<disp-formula id="S2.Ex2">
<mml:math id="M2">
<mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mtext mathvariant="bold">N</mml:mtext>
<mml:mi mathvariant="bold">R</mml:mi>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mrow>
<mml:munder>
<mml:mo largeop="true" movablelimits="false" symmetric="true">∑</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="bold">G</mml:mi>
<mml:mi mathvariant="bold">j</mml:mi>
</mml:msub>
<mml:mo>∈</mml:mo>
<mml:mi mathvariant="bold">S</mml:mi>
</mml:mrow>
</mml:munder>
<mml:msup>
<mml:mrow>
<mml:mo stretchy="false">|</mml:mo>
<mml:msub>
<mml:mtext mathvariant="bold">r</mml:mtext>
<mml:msup>
<mml:mi mathvariant="bold">j</mml:mi>
<mml:mo>*</mml:mo>
</mml:msup>
</mml:msub>
<mml:mo stretchy="false">|</mml:mo>
</mml:mrow>
<mml:mi mathvariant="bold">p</mml:mi>
</mml:msup>
</mml:mrow>
</mml:mrow>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula>
<p>Finally, after L time permutations, we can obtain the null distribution of <inline-formula><mml:math id="INEQ1"><mml:mrow><mml:mrow><mml:mi>E</mml:mi><mml:mo>⁢</mml:mo><mml:msup><mml:mi>S</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>⁢</mml:mo><mml:mi>u</mml:mi><mml:mo>⁢</mml:mo><mml:mi>l</mml:mi><mml:mo>⁢</mml:mo><mml:mi>l</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>E</mml:mi><mml:mo>⁢</mml:mo><mml:msubsup><mml:mi>S</mml:mi><mml:mn>1</mml:mn><mml:mrow><mml:mi>n</mml:mi><mml:mo>⁢</mml:mo><mml:mi>u</mml:mi><mml:mo>⁢</mml:mo><mml:mi>l</mml:mi><mml:mo>⁢</mml:mo><mml:mi>l</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:mi>E</mml:mi><mml:mo>⁢</mml:mo><mml:msubsup><mml:mi>S</mml:mi><mml:mn>2</mml:mn><mml:mrow><mml:mi>n</mml:mi><mml:mo>⁢</mml:mo><mml:mi>u</mml:mi><mml:mo>⁢</mml:mo><mml:mi>l</mml:mi><mml:mo>⁢</mml:mo><mml:mi>l</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:mrow><mml:mi>E</mml:mi><mml:mo>⁢</mml:mo><mml:msubsup><mml:mi>S</mml:mi><mml:mi>l</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>⁢</mml:mo><mml:mi>u</mml:mi><mml:mo>⁢</mml:mo><mml:mi>l</mml:mi><mml:mo>⁢</mml:mo><mml:mi>l</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>. To control the effect of the gene sets with varying sizes, the observed <italic>E</italic><italic>S</italic>(<italic>S</italic>) is normalized by the average value and standard deviation of the permutated <inline-formula><mml:math id="INEQ3"><mml:mrow><mml:mi>E</mml:mi><mml:mo>⁢</mml:mo><mml:msubsup><mml:mi>S</mml:mi><mml:mi>S</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>⁢</mml:mo><mml:mi>u</mml:mi><mml:mo>⁢</mml:mo><mml:mi>l</mml:mi><mml:mo>⁢</mml:mo><mml:mi>l</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:math></inline-formula>, defined by <inline-formula><mml:math id="INEQ4"><mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mo>⁢</mml:mo><mml:mi>E</mml:mi><mml:mo>⁢</mml:mo><mml:msup><mml:mi>S</mml:mi><mml:mi>S</mml:mi></mml:msup></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:mi>E</mml:mi><mml:mo>⁢</mml:mo><mml:msup><mml:mi>S</mml:mi><mml:mi>S</mml:mi></mml:msup></mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:mi>m</mml:mi><mml:mo>⁢</mml:mo><mml:mi>e</mml:mi><mml:mo>⁢</mml:mo><mml:mi>a</mml:mi><mml:mo>⁢</mml:mo><mml:mi>n</mml:mi><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>E</mml:mi><mml:mo>⁢</mml:mo><mml:msubsup><mml:mi>S</mml:mi><mml:mi>S</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>⁢</mml:mo><mml:mi>u</mml:mi><mml:mo>⁢</mml:mo><mml:mi>l</mml:mi><mml:mo>⁢</mml:mo><mml:mi>l</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mi>S</mml:mi><mml:mo>⁢</mml:mo><mml:mi>D</mml:mi><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>E</mml:mi><mml:mo>⁢</mml:mo><mml:msubsup><mml:mi>S</mml:mi><mml:mi>S</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>⁢</mml:mo><mml:mi>u</mml:mi><mml:mo>⁢</mml:mo><mml:mi>l</mml:mi><mml:mo>⁢</mml:mo><mml:mi>l</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:math></inline-formula>. The <italic>P-</italic>values were finally calculated from the NES for each chemicals related gene set.</p>
<p>This study conducted a total of 5,000 permutations to calculate the empirical distributions of GSEA statistics of each chemical. And the chemicals related gene sets with <italic>P</italic> &lt; 0.05 are considered statistically significant. Previous research provides the detailed descriptions regarding this approach (<xref ref-type="bibr" rid="B67">Zhao et al., 2018</xref>). Similarly, all mRNA expression profile from GEO were analyzed using the same approach (<xref ref-type="bibr" rid="B59">Weng et al., 2011</xref>).</p>
</sec>
</sec>
<sec id="S3">
<title>Results</title>
<sec id="S3.SS1">
<title>Environmental Chemicals Associated With Colorectal Cancer</title>
<p>From the CRC GWAS summary datasets, we identified 175 chemicals that were significantly associated with colon cancer (including 34 for colon tissue and 141 for whole blood) as well as 103 chemicals significantly associated with rectal cancer (including 20 for rectal tissue and 83 for whole blood) (<italic>P</italic> &lt; 0.05; <xref ref-type="supplementary-material" rid="SM1">Supplementary Tables S1</xref>, <xref ref-type="supplementary-material" rid="SM1">S2</xref>). For the expression profile of CRC, we identified 1,198 significant chemicals (<italic>P</italic> &lt; 0.05; <xref ref-type="supplementary-material" rid="SM1">Supplementary Table S3</xref>).</p>
<p>After a comparative analysis of the TWAS and mRNA expression profile GSEA results, we significantly detected several chemicals associated with the colon cancer and rectal cancer (<italic>P</italic> &lt; 0.05). For colon cancer, 104 common chemicals were detected, including 83 in colon tissue and 24 in blood tissue, and 3 in both tissues (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table S4</xref>),such as Antirheumatic Agents (<italic>P</italic>-value1 = 0.0244, <italic>P-</italic>value2 = 0.0230), Chenodeoxycholic Acid (<italic>P-</italic>value1 = 0.0002, <italic>P-</italic>value2 = 0.0002) and Trientine (<italic>P-</italic>value1 = 0.0464, <italic>P-</italic>value2 = 0.0314; Supplementary note: In this paragraph, <italic>P-</italic>value1 is <italic>P-</italic>value in GWAS dataset and <italic>P-</italic>value2 is <italic>P-</italic>value in mRNA expression profile). For rectal cancer, 51 common chemicals were discovered, including 12 in rectum tissue and 39 in blood tissue (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table S5</xref>). <xref ref-type="table" rid="T1">Tables 1</xref>, <xref ref-type="table" rid="T2">2</xref> summarized the top 10 chemicals identified for the colon cancer and rectal cancer separately.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>List of top ten chemicals identified for colon cancer after a comparative of GWAS and mRNA GSEA results.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chemical Name</td>
<td align="center" colspan="1" rowspan="1" valign="top"><italic>P</italic>-value1<sup>a</sup></td>
<td align="center" colspan="1" rowspan="1" valign="top"><italic>P</italic>-value2<sup>b</sup></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Antirheumatic Agents</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0002</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">LG 100815</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0004</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0004</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Zinc Acetate</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0010</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0004</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Aerosols</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0016</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Titanium dioxide</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0026</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Motexafin gadolinium</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0046</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0006</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Clofibric Acid</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0052</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Vitallium</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0052</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Raloxifene Hydrochloride</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0066</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Soman</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0094</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0002</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic><sup><italic>a</italic></sup>P-value1: P-value in GWAS dataset. <sup><italic>b</italic></sup>P-value2: P-value in mRNA expression profile.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>List of top ten chemicals identified for rectal cancer after a comparative of GWAS and mRNA GSEA results.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chemical name</td>
<td align="center" colspan="1" rowspan="1" valign="top"><italic>P-</italic>value1<sup>a</sup></td>
<td align="center" colspan="1" rowspan="1" valign="top"><italic>P</italic>-value2<sup>b</sup></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">NAD</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0020</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0004</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sulindac sulfide</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0052</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Casticin</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0086</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Benz(a)anthracene</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0124</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Methylnitronitrosoguanidine</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0132</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Afimoxifene</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0134</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">4-phenylbutyric acid</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0150</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0004</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nickel</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0178</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ochratoxin A</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0180</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Promethazine</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0196</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0006</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic><sup><italic>a</italic></sup>P-value1: P-value in GWAS dataset. <sup><italic>b</italic></sup>P-value2: P-value in mRNA expression profile.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
<p>Meanwhile, <xref ref-type="table" rid="T3">Table 3</xref> shows the common significant environmental chemicals between colon cancer and rectal cancer. We detected 5 chemicals, including methylnitronitrosoguanidine (<italic>P-</italic>value1 = 0.0394, <italic>P-</italic>value2 = 0.0132, <italic>P-</italic>value3 = 0.0002), isoniazid (<italic>P-</italic>value1 = 0.0164, <italic>P-</italic>value2 = 0.0262, <italic>P-</italic>value3 = 0.0068), PD 0325901 (<italic>P-</italic>value1 = 0.0348, <italic>P-</italic>value2 = 0.0406, <italic>P-</italic>value3 = 0.0012), sulindac sulfide (<italic>P-</italic>value1 = 0.0374, <italic>P-</italic>value2 = 0.0052, <italic>P-</italic>value2 = 0.0002), importazole (<italic>P-</italic>value1 = 0.0378, <italic>P-</italic>value2 = 0.0450, <italic>P-</italic>value3 = 0.0224; Supplementary note: In this paragraph, <italic>P-</italic>value1 is <italic>P-</italic>value in colon GWAS dataset, <italic>P-</italic>value2 is <italic>P-</italic>value in rectal GWAS dataset, <italic>P-</italic>value3 is <italic>P-</italic>value in mRNA expression profile). The specific technology roadmap and Venn diagram are shown in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>The common significant chemicals between colon cancer and rectal cancer GSEA results.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chemical name</td>
<td align="center" colspan="1" rowspan="1" valign="top"><italic>P</italic>-value1<sup>a</sup></td>
<td align="center" colspan="1" rowspan="1" valign="top"><italic>P</italic>-value2<sup>b</sup></td>
<td align="center" colspan="1" rowspan="1" valign="top"><italic>P</italic>-value3<sup>c</sup></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Methylnitronitrosoguanidine</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0394</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0132</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Isoniazid</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0164</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0262</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0068</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">PD 0325901</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0348</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0406</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0012</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sulindac sulfide</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0374</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0052</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Importazole</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0378</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0450</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0224</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic><sup><italic>a</italic></sup>P-value1: P-value in colon GWAS dataset. <sup><italic>b</italic></sup>P-value2: P-value in rectal GWAS dataset. <sup><italic>c</italic></sup>P-value3: P-value in mRNA expression profile.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Technology roadmap. First, the GWAS dataset of colon cancer and rectal cancer were downloaded from GeneATLAS, a large database based on the UK Biobank cohort. Meanwhile, we obtained mRNA expression profiles of CRC from NCBI-GEO. The software FUSION was used to assess the CRC GWAS summary data for tissue-related TWAS analysis. The chemicals related gene sets were then generated by the CTD. Subsequently, chemical-related gene set enrichment analysis (GSEA) was conducted to detect the association between chemicals and CRC. Finally, the Venn diagram showed the significant chemicals associated with colorectal cancer.</p>
</caption>
<graphic xlink:href="fgene-11-00385-g001"></graphic>
</fig>
</sec>
</sec>
<sec id="S4">
<title>Discussion</title>
<p>CRC is the fourth deadliest cancer lead to 900,000 deaths worldwide annually (<xref ref-type="bibr" rid="B12">Dekker et al., 2019</xref>). It has become a global public health problem due to its high morbidity and mortality worldwide. Both genetic and environmental factors play significant roles in the etiology of colorectal cancer. Cancer risk factors include biological agents (infection), exposure to synthetic chemicals, and lifestyle factors, which together contribute to the development of 70–95% of cancers (<xref ref-type="bibr" rid="B62">Wu et al., 2016</xref>). Several chemicals have been reported promote the tumorigenesis and tumor development of CRC (<xref ref-type="bibr" rid="B1">Abolhassani et al., 2019</xref>; <xref ref-type="bibr" rid="B8">Cernigliaro et al., 2019</xref>; <xref ref-type="bibr" rid="B29">Jones et al., 2019</xref>). This provides a new clue for us to prevent the occurrence of colorectal cancer. Meanwhile, except for the standard treatment, many chemicals have been reported to inhibit CRC in recent years. For example, the anti-colorectal cancer effect of awsonaringenin (LSG), a flavonoid compound, has been demonstrated in previous research (<xref ref-type="bibr" rid="B2">Anwar et al., 2018</xref>). Environmental chemicals are related to various malignant tumors besides CRC. For example, acrylamide, benzo(a)pyrene and polychlorinated biphenyls can induce carcinogenesis for cytotoxicity and DNA damage to hepatic cells (<xref ref-type="bibr" rid="B13">Erkekoglu et al., 2017</xref>). The discovery for the active substance in chemicals related cancer is of great significance for the treatment to tumor patients. Since the chemicals environmental exposure is usually complex and accurately measuring exposure levels <italic>in vivo</italic> is still with many objective problems, we try to explore the relationships between chemicals and cancer in an easier way.</p>
<p>In this study, we extended the classical GSEA approach to detect associations between chemicals and CRC using TWAS data and gene expression datasets. We identified several chemicals showing genetic correlation evidence with the CRC.</p>
<p>We identified several significant chemicals for the colon cancer, such as aspirin and titanium dioxide, which have been reported by previous study. Aspirin, a well-known antirheumatic drug, is proved that can prolong the survival of patients with colorectal cancer and activate T cell-mediated antitumor immunity (<xref ref-type="bibr" rid="B23">Hamada et al., 2017</xref>). Bettini, Boutet-Robinet et al. has reported that daily oral food-grade titanium dioxide (TiO2) intake is related to an chronic intestinal inflammation and will increase the risk of carcinogenesis (<xref ref-type="bibr" rid="B4">Bettini et al., 2017</xref>).</p>
<p>NAD and Nickel are two remarkable chemicals associated with rectal cancer. A recent study revealed that increased nicotinamide adenine dinucleotide pool suppressed reactive oxygen species level to promote progression of colon cancer (<xref ref-type="bibr" rid="B26">Hong et al., 2019</xref>). In a previous study, trace elements in normal and cancerous tissue which obtained from 18 patients suffering from colon and rectum cancer were quantitatively determined by X-ray fluorescence, and the result showed that Nickel elevated in cancerous tissues (<xref ref-type="bibr" rid="B19">Gregoriadis et al., 1983</xref>).</p>
<p>Five overlapped chemicals have been identified associated with CRC, including the carcinogens methylnitronitrosoguanidine, isoniazid. And PD 0325901, sulindac sulfide and importazole have the ability to inhibit the carcinogenesis and development of cancer.</p>
<p>Methylnitronitrosoguanidine (MNNG) is anticipated to be declared a human carcinogen based on sufficient evidence of its carcinogenicity from investigations involving animal models. MNNG caused tumors at different tissue sites in several animal model species by several different exposure routes. Research indicated that the intrarectal infusion of MNNG into large intestine of rats can cause tumors (<xref ref-type="bibr" rid="B57">Tsukamoto et al., 2015</xref>; <xref ref-type="bibr" rid="B50">U.S. Department of Health and Human Services, 2016</xref>).</p>
<p>Isoniazid (INH) is an irreversible inhibitor of Monoamine oxidase A (MAOA) that is widely regarded as a major anti-tuberculosis drug (<xref ref-type="bibr" rid="B65">Zareifopoulos and Panayiotakopoulos, 2017</xref>). MAOA is a mitochondrial-bound enzyme. It was confirmed that MAOA may promote the progression of prostate cancer by mediating EMT (<xref ref-type="bibr" rid="B60">Wu et al., 2014</xref>; <xref ref-type="bibr" rid="B39">Lv et al., 2018</xref>). However, because conflicting results have been reported for the importance of MAOA in HCC and cholangiocarcinoma (<xref ref-type="bibr" rid="B28">Huang et al., 2012</xref>; <xref ref-type="bibr" rid="B34">Li et al., 2014</xref>), the role of MAOA may vary across cancer types. Lee et al. demonstrated that Monoamine Oxidase Inhibitors (MAOIs) are associated with increased colorectal cancer risk (adjusted OR = 1.22, 95% CI = 1.06-1.41; <xref ref-type="bibr" rid="B33">Lee et al., 2017</xref>).</p>
<p>PD 0325901 is an MEK inhibitor. Interestingly, <xref ref-type="bibr" rid="B49">Roper et al. (2014)</xref> have shown PI3K/MEK inhibition combined with NVP-BKM120 and PD-0325901 treatment can induce tumor progression in a wild-type PIK3CA mouse model, KRAS mutant CRC, based on the inhibition of mTORC1 and MCL-1 and the activation of BIM. Moreover, PD0325901 was reported to inhibit oxaliplatin-induced neuropathy and enhance oxaliplatin efficacy (<xref ref-type="bibr" rid="B56">Tsubaki et al., 2015</xref>).</p>
<p>Liggett et al. observed that the non-steroidal anti-inflammatory drug sulindac sulfide inhibits the expression of the potential oncogene structural protein nesprin-2 in CRC cells (<xref ref-type="bibr" rid="B36">Liggett et al., 2014</xref>). The results of another study suggested the inhibition of sulindac sulfide on the growth of colon cancer cells and down-regulation of specific transcription factors (<xref ref-type="bibr" rid="B35">Li et al., 2015</xref>). Furthermore, the inhibitory effects of 5-fluorouracil and oxaliplatin on human CRC cell survival were demonstrated to be synergistically enhanced by sulindac sulfide (<xref ref-type="bibr" rid="B15">Flis and Splwinski, 2009</xref>).</p>
<p>Importazole is a small molecule inhibitor of the transport receptor importin-β (<xref ref-type="bibr" rid="B52">Soderholm et al., 2011</xref>) that can inhibit the proliferation and induce apoptosis of multiple myeloma cells by blocking the NF-KB signaling pathway (<xref ref-type="bibr" rid="B63">Yan et al., 2015</xref>). Moreover, intravenous administration of the specific KPNB1 inhibitor importazole was effective in reducing the volume and weight of prostate cancer tumor in mice inoculated with PC3 PCa cells (<xref ref-type="bibr" rid="B64">Yang et al., 2019</xref>). Thus, the results of the above studies show that importazole can inhibit tumors.</p>
<p>We conducted a large scale correlation study between colorectal cancer and environmental chemicals and explored the associations between chemicals and colorectal cancer systematically. Our analysis approach has two advantages. Firstly, we identified interaction between chemicals and genes directly. From the perspective of genome, the result is more stable to overcome the shortcomings of traditional exposure measurement methods. From the perspective of benefit, genome-wide summary data usually can be obtained online conveniently. Secondly, our research analyzed summaries of TWAS and mRNA expression profiles, in other words, we made a comprehensive analysis in the DNA and mRNA expression levels. This is helpful to narrow the range of chemicals related candidate genes on the basis of traditional GWAS analysis and make the results more reliable. Current research shows that chemicals in environmental factors have great significance in the etiology of multiple cancers (<xref ref-type="bibr" rid="B55">Thompson et al., 2015</xref>). However, we only researched the colon cancer and rectal cancer. As cancer sequencing gene data sets increasing, we will apply our method to large-scale studies of cancer gene-environment interactions.</p>
<p>In summary, we conducted an integrative analysis of GWAS summary data, mRNA expression profiles and chemical-gene interaction networks. Tools such as TWAS and GSEA helped linking these datasets and identifying several chemicals associated with CRC. The results of our study evaluate the associations between CRC and chemicals systematically, and provide new clues for revealing the association between chemicals and genes and their effects on cancer. Furthermore, our method can be used to analyze other chemicals and complex malignant disease, which is helpful for assessing the relationship between environmental exposure and cancer.</p>
</sec>
<sec id="S5" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>Publicly available datasets were analyzed in this study. This data can be found here: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/gds/">https://www.ncbi.nlm.nih.gov/gds/</ext-link> (GSE106582), <ext-link ext-link-type="uri" xlink:href="http://geneatlas.roslin.ed.ac.uk/">http://geneatlas.roslin.ed.ac.uk/</ext-link> (categories C18, categories C20), <ext-link ext-link-type="uri" xlink:href="http://gusevlab.org/projects/fusion/">http://gusevlab.org/projects/fusion/</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://ctdbase.org/">http://ctdbase.org/</ext-link>.</p>
</sec>
<sec id="S6">
<title>Author Contributions</title>
<p>XT and SH designed experiments. XT, HT, ZL, and YL reviewed and downloaded the original data. XT, LG, and LX processed and analyzed the data. XT, CH, and JM analyzed experimental results. XT, HT, and SH wrote the manuscript.</p>
</sec>
<sec id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by grants from the Innovation Capacity Support Plan of Shaanxi Province 2018TD−002.</p>
</fn>
</fn-group>
<fn-group>
<fn id="footnote1">
<label>1</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://geneatlas.roslin.ed.ac.uk/">http://geneatlas.roslin.ed.ac.uk/</ext-link>
</p>
</fn>
<fn id="footnote2">
<label>2</label>
<p>
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/gds/">https://www.ncbi.nlm.nih.gov/gds/</ext-link>
</p>
</fn>
<fn id="footnote3">
<label>3</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://gusevlab.org/projects/fusion/">http://gusevlab.org/projects/fusion/</ext-link>
</p>
</fn>
<fn id="footnote4">
<label>4</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://ctdbase.org/">http://ctdbase.org/</ext-link>
</p>
</fn>
</fn-group>
<sec id="S8" sec-type="supplementary material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2020.00385/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2020.00385/full#supplementary-material</ext-link></p>
<supplementary-material content-type="local-data" id="SM1">
<media xlink:href="Data_Sheet_1.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abolhassani</surname><given-names>M.</given-names></name><name><surname>Asadikaram</surname><given-names>G.</given-names></name><name><surname>Paydar</surname><given-names>P.</given-names></name><name><surname>Fallah</surname><given-names>H.</given-names></name><name><surname>Aghaee-Afshar</surname><given-names>M.</given-names></name><name><surname>Moazed</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Organochlorine and organophosphorous pesticides may induce colorectal cancer; A case-control study.</article-title>
<source/><italic>Ecotoxicol. Environ. Saf.</italic>
<volume>178</volume>
<fpage>168</fpage>–<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1016/j.ecoenv.2019.04.030</pub-id>
<pub-id pub-id-type="pmid">31004929</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anwar</surname><given-names>A.</given-names></name><name><surname>Uddin</surname><given-names>N.</given-names></name><name><surname>Siddiqui</surname><given-names>B. S.</given-names></name><name><surname>Siddiqui</surname><given-names>R. A.</given-names></name><name><surname>Begum</surname><given-names>S.</given-names></name><name><surname>Choudhary</surname><given-names>M. I.</given-names></name></person-group> (<year>2018</year>). <article-title>A natural flavonoid lawsonaringenin induces cell cycle arrest and apoptosis in HT-29 colorectal cancer cells by targeting multiple signalling pathways.</article-title>
<source/><italic>Mol. Biol. Rep.</italic>
<volume>45</volume>
<fpage>1339</fpage>–<lpage>1348</lpage>. <pub-id pub-id-type="doi">10.1007/s11033-018-4294-5</pub-id>
<pub-id pub-id-type="pmid">30088202</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>T.</given-names></name><name><surname>Wilhite</surname><given-names>S. E.</given-names></name><name><surname>Ledoux</surname><given-names>P.</given-names></name><name><surname>Evangelista</surname><given-names>C.</given-names></name><name><surname>Kim</surname><given-names>I. F.</given-names></name><name><surname>Tomashevsky</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>NCBI GEO: archive for functional genomics data sets–update.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>41</volume>
<fpage>D991</fpage>–<lpage>D995</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gks1193</pub-id>
<pub-id pub-id-type="pmid">23193258</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bettini</surname><given-names>S.</given-names></name><name><surname>Boutet-Robinet</surname><given-names>E.</given-names></name><name><surname>Cartier</surname><given-names>C.</given-names></name><name><surname>Comera</surname><given-names>C.</given-names></name><name><surname>Gaultier</surname><given-names>E.</given-names></name><name><surname>Dupuy</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Food-grade TiO2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>7</volume>:<issue>40373</issue>. <pub-id pub-id-type="doi">10.1038/srep40373</pub-id>
<pub-id pub-id-type="pmid">28106049</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bokemeyer</surname><given-names>C.</given-names></name><name><surname>Bondarenko</surname><given-names>I.</given-names></name><name><surname>Hartmann</surname><given-names>J.</given-names></name><name><surname>De Braud</surname><given-names>F.</given-names></name><name><surname>Schuch</surname><given-names>G.</given-names></name><name><surname>Zubel</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study.</article-title>
<source/><italic>Ann. Oncol.</italic>
<volume>22</volume>
<fpage>1535</fpage>–<lpage>1546</lpage>. <pub-id pub-id-type="doi">10.1093/annonc/mdq632</pub-id><pub-id pub-id-type="pmid">21228335</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname><given-names>F.</given-names></name><name><surname>Ferlay</surname><given-names>J.</given-names></name><name><surname>Soerjomataram</surname><given-names>I.</given-names></name><name><surname>Siegel</surname><given-names>R. L.</given-names></name><name><surname>Torre</surname><given-names>L. A.</given-names></name><name><surname>Jemal</surname><given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.</article-title>
<source/><italic>CA Cancer J. Clin.</italic>
<volume>68</volume>
<fpage>394</fpage>–<lpage>424</lpage>. <pub-id pub-id-type="doi">10.3322/caac.21492</pub-id>
<pub-id pub-id-type="pmid">30207593</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canela-Xandri</surname><given-names>O.</given-names></name><name><surname>Rawlik</surname><given-names>K.</given-names></name><name><surname>Tenesa</surname><given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>An atlas of genetic associations in UK Biobank.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>50</volume>
<fpage>1593</fpage>–<lpage>1599</lpage>. <pub-id pub-id-type="doi">10.1038/s41588-018-0248-z</pub-id>
<pub-id pub-id-type="pmid">30349118</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cernigliaro</surname><given-names>C.</given-names></name><name><surname>D’Anneo</surname><given-names>A.</given-names></name><name><surname>Carlisi</surname><given-names>D.</given-names></name><name><surname>Giuliano</surname><given-names>M.</given-names></name><name><surname>Marino Gammazza</surname><given-names>A.</given-names></name><name><surname>Barone</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Ethanol-mediated stress promotes autophagic survival and aggressiveness of colon cancer cells via activation of Nrf2/HO-1 pathway.</article-title>
<source/><italic>Cancers</italic>
<volume>11</volume>:<issue>505</issue>. <pub-id pub-id-type="doi">10.3390/cancers11040505</pub-id>
<pub-id pub-id-type="pmid">30974805</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charmpi</surname><given-names>K.</given-names></name><name><surname>Ycart</surname><given-names>B.</given-names></name></person-group> (<year>2015</year>). <article-title>Weighted kolmogorov smirnov testing: an alternative for gene set enrichment analysis.</article-title>
<source/><italic>Stat. Appl. Genet. Mol. Biol.</italic>
<volume>14</volume>
<fpage>279</fpage>–<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1515/sagmb-2014-0077</pub-id>
<pub-id pub-id-type="pmid">26030794</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>A. P.</given-names></name><name><surname>Grondin</surname><given-names>C. J.</given-names></name><name><surname>Johnson</surname><given-names>R. J.</given-names></name><name><surname>Sciaky</surname><given-names>D.</given-names></name><name><surname>King</surname><given-names>B. L.</given-names></name><name><surname>McMorran</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The comparative toxicogenomics database: update 2017.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>45</volume>
<fpage>D972</fpage>–<lpage>D978</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw838</pub-id>
<pub-id pub-id-type="pmid">27651457</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>A. P.</given-names></name><name><surname>Murphy</surname><given-names>C. G.</given-names></name><name><surname>Johnson</surname><given-names>R.</given-names></name><name><surname>Lay</surname><given-names>J. M.</given-names></name><name><surname>Lennon-Hopkins</surname><given-names>K.</given-names></name><name><surname>Saraceni-Richards</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>The comparative toxicogenomics database: update 2013.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>41</volume>
<fpage>D1104</fpage>–<lpage>D1114</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gks994</pub-id>
<pub-id pub-id-type="pmid">23093600</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dekker</surname><given-names>E.</given-names></name><name><surname>Tanis</surname><given-names>P. J.</given-names></name><name><surname>Vleugels</surname><given-names>J. L. A.</given-names></name><name><surname>Kasi</surname><given-names>P. M.</given-names></name><name><surname>Wallace</surname><given-names>M. B.</given-names></name></person-group> (<year>2019</year>). <article-title>Colorectal cancer.</article-title>
<source/><italic>Lancet</italic>
<volume>394</volume>
<fpage>1467</fpage>–<lpage>1480</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(19)32319-0</pub-id><pub-id pub-id-type="pmid">31631858</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erkekoglu</surname><given-names>P.</given-names></name><name><surname>Oral</surname><given-names>D.</given-names></name><name><surname>Chao</surname><given-names>M. W.</given-names></name><name><surname>Kocer-Gumusel</surname><given-names>B.</given-names></name></person-group> (<year>2017</year>). <article-title>Hepatocellular carcinoma and possible chemical and biological causes: a review.</article-title>
<source/><italic>J. Environ. Pathol. Toxicol. Oncol.</italic>
<volume>36</volume>
<fpage>171</fpage>–<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1615/JEnvironPatholToxicolOncol.2017020927</pub-id>
<pub-id pub-id-type="pmid">29199597</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferlay</surname><given-names>J.</given-names></name><name><surname>Colombet</surname><given-names>M.</given-names></name><name><surname>Soerjomataram</surname><given-names>I.</given-names></name><name><surname>Mathers</surname><given-names>C.</given-names></name><name><surname>Parkin</surname><given-names>D. M.</given-names></name><name><surname>Pineros</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.</article-title>
<source/><italic>Int. J. Cancer</italic>
<volume>144</volume>
<fpage>1941</fpage>–<lpage>1953</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.31937</pub-id>
<pub-id pub-id-type="pmid">30350310</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flis</surname><given-names>S.</given-names></name><name><surname>Splwinski</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Inhibitory effects of 5-fluorouracil and oxaliplatin on human colorectal cancer cell survival are synergistically enhanced by sulindac sulfide.</article-title>
<source/><italic>Anticancer Res.</italic>
<volume>29</volume>
<fpage>435</fpage>–<lpage>441</lpage>.<pub-id pub-id-type="pmid">19331183</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giacchetti</surname><given-names>S. P. B.</given-names></name><name><surname>Zidani</surname><given-names>R.</given-names></name><name><surname>Le Bail</surname><given-names>N.</given-names></name><name><surname>Faggiuolo</surname><given-names>R.</given-names></name><name><surname>Focan</surname><given-names>C.</given-names></name></person-group> (<year>2000</year>). <article-title>Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil–leucovorin as first-line treatment of metastatic colorectal cancer.</article-title>
<source/><italic>J. Clin. Oncol.</italic>
<volume>18</volume>
<fpage>136</fpage>–<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1200/JCO.2000.18.1.136</pub-id>
<pub-id pub-id-type="pmid">10623704</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>R. M.</given-names></name><name><surname>Sargent</surname><given-names>D. J.</given-names></name><name><surname>Morton</surname><given-names>R. F.</given-names></name><name><surname>Fuchs</surname><given-names>C. S.</given-names></name><name><surname>Ramanathan</surname><given-names>R. K.</given-names></name><name><surname>Williamson</surname><given-names>S. K.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.</article-title>
<source/><italic>J. Clin. Oncol.</italic>
<volume>22</volume>
<fpage>23</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1200/JCO.2004.09.046</pub-id>
<pub-id pub-id-type="pmid">14665611</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Lei</surname><given-names>Y.</given-names></name><name><surname>Qian</surname><given-names>Y.</given-names></name><name><surname>Tan</surname><given-names>X.</given-names></name><name><surname>Han</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Transcriptome-wide association study identifies multiple genes and pathways associated with pancreatic cancer.</article-title>
<source/><italic>Cancer Med.</italic>
<volume>7</volume>
<fpage>5727</fpage>–<lpage>5732</lpage>. <pub-id pub-id-type="doi">10.1002/cam4.1836</pub-id>
<pub-id pub-id-type="pmid">30334361</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gregoriadis</surname><given-names>G. C.</given-names></name><name><surname>Apostolidis</surname><given-names>N. S.</given-names></name><name><surname>Romanos</surname><given-names>A. N.</given-names></name><name><surname>Paradellis</surname><given-names>T. P.</given-names></name></person-group> (<year>1983</year>). <article-title>A comparative study of trace elements in normal and cancerous colorectal tissues.</article-title>
<source/><italic>Cancer</italic>
<volume>52</volume>
<fpage>508</fpage>–<lpage>519</lpage>. <pub-id pub-id-type="doi">10.1002/1097-0142(19830801)52:3&lt;508::AID-CNCR2820520322&gt;3.0.CO;2-8</pub-id><pub-id pub-id-type="pmid">6861088</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grondin</surname><given-names>C. J.</given-names></name><name><surname>Davis</surname><given-names>A. P.</given-names></name><name><surname>Wiegers</surname><given-names>T. C.</given-names></name><name><surname>Wiegers</surname><given-names>J. A.</given-names></name><name><surname>Mattingly</surname><given-names>C. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Accessing an expanded exposure science module at the comparative toxicogenomics database.</article-title>
<source/><italic>Environ. Health Perspect.</italic>
<volume>126</volume>:<issue>014501</issue>. <pub-id pub-id-type="doi">10.1289/EHP2873</pub-id>
<pub-id pub-id-type="pmid">29351546</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gusev</surname><given-names>A.</given-names></name><name><surname>Mancuso</surname><given-names>N.</given-names></name><name><surname>Won</surname><given-names>H.</given-names></name><name><surname>Kousi</surname><given-names>M.</given-names></name><name><surname>Finucane</surname><given-names>H. K.</given-names></name><name><surname>Reshef</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>50</volume>
<fpage>538</fpage>–<lpage>548</lpage>. <pub-id pub-id-type="doi">10.1038/s41588-018-0092-1</pub-id>
<pub-id pub-id-type="pmid">29632383</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gustavsson</surname><given-names>B.</given-names></name><name><surname>Carlsson</surname><given-names>G.</given-names></name><name><surname>Machover</surname><given-names>D.</given-names></name><name><surname>Petrelli</surname><given-names>N.</given-names></name><name><surname>Roth</surname><given-names>A.</given-names></name><name><surname>Schmoll</surname><given-names>H. J.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>A review of the evolution of systemic chemotherapy in the management of colorectal cancer.</article-title>
<source/><italic>Clin. Colorectal Cancer</italic>
<volume>14</volume>
<fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.clcc.2014.11.002</pub-id>
<pub-id pub-id-type="pmid">25579803</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamada</surname><given-names>T.</given-names></name><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Qian</surname><given-names>Z. R.</given-names></name><name><surname>Masugi</surname><given-names>Y.</given-names></name><name><surname>Nowak</surname><given-names>J. A.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Aspirin use and colorectal cancer survival according to tumor CD274 (Programmed Cell Death 1 Ligand 1) expression status.</article-title>
<source/><italic>J. Clin. Oncol.</italic>
<volume>35</volume>
<fpage>1836</fpage>–<lpage>1844</lpage>. <pub-id pub-id-type="doi">10.1200/JCO.2016.70.7547</pub-id>
<pub-id pub-id-type="pmid">28406723</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammerschlag</surname><given-names>A. R.</given-names></name><name><surname>Stringer</surname><given-names>S.</given-names></name><name><surname>de Leeuw</surname><given-names>C. A.</given-names></name><name><surname>Sniekers</surname><given-names>S.</given-names></name><name><surname>Taskesen</surname><given-names>E.</given-names></name><name><surname>Watanabe</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Genome-wide association analysis of insomnia complaints identifies risk genes and genetic overlap with psychiatric and metabolic traits.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>49</volume>
<fpage>1584</fpage>–<lpage>1592</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3888</pub-id>
<pub-id pub-id-type="pmid">28604731</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Prakash</surname><given-names>N. T.</given-names></name><name><surname>Tinkov</surname><given-names>A. A.</given-names></name><name><surname>Skalny</surname><given-names>A. V.</given-names></name><name><surname>Wen</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Integrating genome-wide association study summaries and element-gene interaction datasets identified multiple associations between elements and complex diseases.</article-title>
<source/><italic>Genet. Epidemiol.</italic>
<volume>42</volume>
<fpage>168</fpage>–<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1002/gepi.22106</pub-id>
<pub-id pub-id-type="pmid">29265413</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>S. M.</given-names></name><name><surname>Hwang</surname><given-names>S. W.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Park</surname><given-names>C. W.</given-names></name><name><surname>Ryu</surname><given-names>Y. M.</given-names></name><name><surname>Jung</surname><given-names>J. H.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Increased nicotinamide adenine dinucleotide pool promotes colon cancer progression by suppressing reactive oxygen species level.</article-title>
<source/><italic>Cancer Sci.</italic>
<volume>110</volume>
<fpage>629</fpage>–<lpage>638</lpage>. <pub-id pub-id-type="doi">10.1111/cas.13886</pub-id>
<pub-id pub-id-type="pmid">30457689</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Cheng</surname><given-names>S.</given-names></name><name><surname>Ding</surname><given-names>M.</given-names></name><name><surname>Wen</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Integrative analysis of transcriptome-wide association study and mRNA expression profiles identifies candidate genes associated with autism spectrum disorders.</article-title>
<source/><italic>Autism Res.</italic>
<volume>12</volume>
<fpage>33</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1002/aur.2048</pub-id>
<pub-id pub-id-type="pmid">30561910</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Frampton</surname><given-names>G.</given-names></name><name><surname>Rao</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>K. S.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Lai</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Monoamine oxidase A expression is suppressed in human cholangiocarcinoma via coordinated epigenetic and IL-6-driven events.</article-title>
<source/><italic>Lab. Invest.</italic>
<volume>92</volume>
<fpage>1451</fpage>–<lpage>1460</lpage>. <pub-id pub-id-type="doi">10.1038/labinvest.2012.110</pub-id>
<pub-id pub-id-type="pmid">22906985</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>R. R.</given-names></name><name><surname>DellaValle</surname><given-names>C. T.</given-names></name><name><surname>Weyer</surname><given-names>P. J.</given-names></name><name><surname>Robien</surname><given-names>K.</given-names></name><name><surname>Cantor</surname><given-names>K. P.</given-names></name><name><surname>Krasner</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Ingested nitrate, disinfection by-products, and risk of colon and rectal cancers in the Iowa Women’s Health Study cohort.</article-title>
<source/><italic>Environ. Int.</italic>
<volume>126</volume>
<fpage>242</fpage>–<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1016/j.envint.2019.02.010</pub-id>
<pub-id pub-id-type="pmid">30822653</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khoury</surname><given-names>M. J.</given-names></name><name><surname>Davis</surname><given-names>R.</given-names></name><name><surname>Gwinn</surname><given-names>M.</given-names></name><name><surname>Lindegren</surname><given-names>M. L.</given-names></name><name><surname>Yoon</surname><given-names>P.</given-names></name></person-group> (<year>2005</year>). <article-title>Do we need genomic research for the prevention of common diseases with environmental causes?</article-title>
<source/><italic>Am. J. Epidemiol.</italic>
<volume>161</volume>
<fpage>799</fpage>–<lpage>805</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwi113</pub-id>
<pub-id pub-id-type="pmid">15840611</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kouhara</surname><given-names>J.</given-names></name><name><surname>Yoshida</surname><given-names>T.</given-names></name><name><surname>Nakata</surname><given-names>S.</given-names></name><name><surname>Horinaka</surname><given-names>M.</given-names></name><name><surname>Wakada</surname><given-names>M.</given-names></name><name><surname>Ueda</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Fenretinide up-regulates DR5/TRAIL-R2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines.</article-title>
<source/><italic>Int. J. Oncol.</italic>
<volume>30</volume>
<fpage>679</fpage>–<lpage>687</lpage>. <pub-id pub-id-type="doi">10.3892/ijo.30.3.679</pub-id><pub-id pub-id-type="pmid">17273769</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuipers</surname><given-names>E. J.</given-names></name><name><surname>Grady</surname><given-names>W. M.</given-names></name><name><surname>Lieberman</surname><given-names>D.</given-names></name><name><surname>Seufferlein</surname><given-names>T.</given-names></name><name><surname>Sung</surname><given-names>J. J.</given-names></name><name><surname>Boelens</surname><given-names>P. G.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Colorectal cancer.</article-title>
<source/><italic>Nat. Rev. Dis. Primers</italic>
<volume>1</volume>:<issue>15065</issue>. <pub-id pub-id-type="doi">10.1038/nrdp.2015.65</pub-id>
<pub-id pub-id-type="pmid">27189416</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H. C.</given-names></name><name><surname>Chiu</surname><given-names>W. C.</given-names></name><name><surname>Wang</surname><given-names>T. N.</given-names></name><name><surname>Liao</surname><given-names>Y. T.</given-names></name><name><surname>Chien</surname><given-names>I. C.</given-names></name><name><surname>Lee</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Antidepressants and colorectal cancer: A population-based nested case-control study.</article-title>
<source/><italic>J. Affect. Disord.</italic>
<volume>207</volume>
<fpage>353</fpage>–<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2016.09.057</pub-id>
<pub-id pub-id-type="pmid">27744223</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>X. M.</given-names></name><name><surname>Wang</surname><given-names>Y. H.</given-names></name><name><surname>Feng</surname><given-names>M. X.</given-names></name><name><surname>Liu</surname><given-names>X. J.</given-names></name><name><surname>Zhang</surname><given-names>Y. L.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Monoamine oxidase A suppresses hepatocellular carcinoma metastasis by inhibiting the adrenergic system and its transactivation of EGFR signaling.</article-title>
<source/><italic>J. Hepatol.</italic>
<volume>60</volume>
<fpage>1225</fpage>–<lpage>1234</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhep.2014.02.025</pub-id>
<pub-id pub-id-type="pmid">24607627</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Pathi</surname><given-names>S. S.</given-names></name><name><surname>Safe</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors.</article-title>
<source/><italic>BMC Cancer</italic>
<volume>15</volume>:<issue>974</issue>. <pub-id pub-id-type="doi">10.1186/s12885-015-1956-8</pub-id>
<pub-id pub-id-type="pmid">26673922</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liggett</surname><given-names>J. L.</given-names></name><name><surname>Choi</surname><given-names>C. K.</given-names></name><name><surname>Donnell</surname><given-names>R. L.</given-names></name><name><surname>Kihm</surname><given-names>K. D.</given-names></name><name><surname>Kim</surname><given-names>J. S.</given-names></name><name><surname>Min</surname><given-names>K. W.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Nonsteroidal anti-inflammatory drug sulindac sulfide suppresses structural protein Nesprin-2 expression in colorectal cancer cells.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1840</volume>
<fpage>322</fpage>–<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagen.2013.09.032</pub-id>
<pub-id pub-id-type="pmid">24080406</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>B. M.</given-names></name><name><surname>Nadkarni</surname><given-names>G. N.</given-names></name><name><surname>Tao</surname><given-names>R.</given-names></name><name><surname>Graff</surname><given-names>M.</given-names></name><name><surname>Fornage</surname><given-names>M.</given-names></name><name><surname>Buyske</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Genetics of chronic kidney disease stages across ancestries: the PAGE study.</article-title>
<source/><italic>Front. Genet.</italic>
<volume>10</volume>:<issue>494</issue>
<pub-id pub-id-type="doi">10.3389/fgene.2019.00494</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucas</surname><given-names>A. S.</given-names></name><name><surname>O’Neil</surname><given-names>B. H.</given-names></name><name><surname>Goldberg</surname><given-names>R. M.</given-names></name></person-group> (<year>2011</year>). <article-title>A decade of advances in cytotoxic chemotherapy for metastatic colorectal cancer.</article-title>
<source/><italic>Clin. Colorectal Cancer</italic>
<volume>10</volume>
<fpage>238</fpage>–<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1016/j.clcc.2011.06.012</pub-id>
<pub-id pub-id-type="pmid">21820973</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Repurposing antitubercular agent isoniazid for treatment of prostate cancer.</article-title>
<source/><italic>Biomater. Sci.</italic>
<volume>7</volume>
<fpage>296</fpage>–<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1039/C8BM01189C</pub-id>
<pub-id pub-id-type="pmid">30468220</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manuck</surname><given-names>S. B.</given-names></name><name><surname>McCaffery</surname><given-names>J. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Gene-environment interaction.</article-title>
<source/><italic>Annu. Rev. Psychol.</italic>
<volume>65</volume>
<fpage>41</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-psych-010213-115100</pub-id>
<pub-id pub-id-type="pmid">24405358</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattingly</surname><given-names>C. J.</given-names></name><name><surname>Colby</surname><given-names>G. T.</given-names></name><name><surname>Forrest</surname><given-names>J. N.</given-names></name><name><surname>Boyer</surname><given-names>J. L.</given-names></name></person-group> (<year>2003</year>). <article-title>The comparative toxicogenomics database (CTD).</article-title>
<source/><italic>Environ. Health Perspect.</italic>
<volume>111</volume>
<fpage>793</fpage>–<lpage>795</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.6028</pub-id>
<pub-id pub-id-type="pmid">12760826</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattingly</surname><given-names>C. J.</given-names></name><name><surname>Rosenstein</surname><given-names>M. C.</given-names></name><name><surname>Colby</surname><given-names>G. T.</given-names></name><name><surname>Forrest</surname><given-names>J. N.</given-names><suffix>Jr.</suffix></name><name><surname>Boyer</surname><given-names>J. L.</given-names></name></person-group> (<year>2006</year>). <article-title>The Comparative Toxicogenomics Database (CTD): a resource for comparative toxicological studies.</article-title>
<source/><italic>J. Exp. Zool. A Comp. Exp. Biol.</italic>
<volume>305</volume>
<fpage>689</fpage>–<lpage>692</lpage>. <pub-id pub-id-type="doi">10.1002/jez.a.307</pub-id>
<pub-id pub-id-type="pmid">16902965</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messerlian</surname><given-names>C.</given-names></name><name><surname>Martinez</surname><given-names>R. M.</given-names></name><name><surname>Hauser</surname><given-names>R.</given-names></name><name><surname>Baccarelli</surname><given-names>A. A.</given-names></name></person-group> (<year>2017</year>). <article-title>‘Omics’ and endocrine-disrupting chemicals - new paths forward.</article-title>
<source/><italic>Nat. Rev. Endocrinol.</italic>
<volume>13</volume>
<fpage>740</fpage>–<lpage>748</lpage>. <pub-id pub-id-type="doi">10.1038/nrendo.2017.81</pub-id>
<pub-id pub-id-type="pmid">28707677</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nuotio</surname><given-names>J.</given-names></name><name><surname>Oikonen</surname><given-names>M.</given-names></name><name><surname>Magnussen</surname><given-names>C. G.</given-names></name><name><surname>Jokinen</surname><given-names>E.</given-names></name><name><surname>Laitinen</surname><given-names>T.</given-names></name><name><surname>Hutri-Kahonen</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Cardiovascular risk factors in 2011 and secular trends since 2007: the cardiovascular risk in young finns study.</article-title>
<source/><italic>Scand. J. Public Health</italic>
<volume>42</volume>
<fpage>563</fpage>–<lpage>571</lpage>. <pub-id pub-id-type="doi">10.1177/1403494814541597</pub-id>
<pub-id pub-id-type="pmid">25053467</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pham</surname><given-names>D. N.</given-names></name><name><surname>Leclerc</surname><given-names>D.</given-names></name><name><surname>Levesque</surname><given-names>N.</given-names></name><name><surname>Deng</surname><given-names>L.</given-names></name><name><surname>Rozen</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>beta,beta-carotene 15,15’-monooxygenase and its substrate beta-carotene modulate migration and invasion in colorectal carcinoma cells.</article-title>
<source/><italic>Am. J. Clin. Nutr.</italic>
<volume>98</volume>
<fpage>413</fpage>–<lpage>422</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.113.060996</pub-id>
<pub-id pub-id-type="pmid">23803888</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Wen</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>An integrative analysis of transcriptome-wide association study and mRNA expression profile identified candidate genes for attention-deficit/hyperactivity disorder.</article-title>
<source/><italic>Psychiatry Res.</italic>
<volume>282</volume>:<issue>112639</issue>. <pub-id pub-id-type="doi">10.1016/j.psychres.2019.112639</pub-id>
<pub-id pub-id-type="pmid">31685286</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Shi</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Wu</surname><given-names>G.</given-names></name></person-group> (<year>2018</year>). <article-title>Lidocaine inhibits proliferation and induces apoptosis in colorectal cancer cells by upregulating mir-520a-3p and targeting EGFR.</article-title>
<source/><italic>Pathol. Res. Pract.</italic>
<volume>214</volume>
<fpage>1974</fpage>–<lpage>1979</lpage>. <pub-id pub-id-type="doi">10.1016/j.prp.2018.09.012</pub-id>
<pub-id pub-id-type="pmid">30262429</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raitakari</surname><given-names>O. T.</given-names></name><name><surname>Juonala</surname><given-names>M.</given-names></name><name><surname>Ronnemaa</surname><given-names>T.</given-names></name><name><surname>Keltikangas-Jarvinen</surname><given-names>L.</given-names></name><name><surname>Rasanen</surname><given-names>L.</given-names></name><name><surname>Pietikainen</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Cohort profile: the cardiovascular risk in Young Finns Study.</article-title>
<source/><italic>Int. J. Epidemiol.</italic>
<volume>37</volume>
<fpage>1220</fpage>–<lpage>1226</lpage>. <pub-id pub-id-type="doi">10.1093/ije/dym225</pub-id>
<pub-id pub-id-type="pmid">18263651</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roper</surname><given-names>J.</given-names></name><name><surname>Sinnamon</surname><given-names>M. J.</given-names></name><name><surname>Coffee</surname><given-names>E. M.</given-names></name><name><surname>Belmont</surname><given-names>P.</given-names></name><name><surname>Keung</surname><given-names>L.</given-names></name><name><surname>Georgeon-Richard</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Combination PI3K/MEK inhibition promotes tumor apoptosis and regression in PIK3CA wild-type, KRAS mutant colorectal cancer.</article-title>
<source/><italic>Cancer Lett.</italic>
<volume>347</volume>
<fpage>204</fpage>–<lpage>211</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2014.02.018</pub-id>
<pub-id pub-id-type="pmid">24576621</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="book"><collab>U.S. Department of Health and Human Services</collab> (<year>2016</year>). <source/><italic>14th Report on Carcinogens.</italic>
<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>U.S. Department of health and human services</publisher-name>.</mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>R. L.</given-names></name><name><surname>Miller</surname><given-names>K. D.</given-names></name><name><surname>Jemal</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Cancer statistics, 2017.</article-title>
<source/><italic>CA Cancer J. Clin.</italic>
<volume>67</volume>
<fpage>7</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.3322/caac.21387</pub-id>
<pub-id pub-id-type="pmid">28055103</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soderholm</surname><given-names>J. F.</given-names></name><name><surname>Bird</surname><given-names>S. L.</given-names></name><name><surname>Kalab</surname><given-names>P.</given-names></name><name><surname>Sampathkumar</surname><given-names>Y.</given-names></name><name><surname>Hasegawa</surname><given-names>K.</given-names></name><name><surname>Uehara-Bingen</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Importazole, a small molecule inhibitor of the transport receptor importin-beta.</article-title>
<source/><italic>ACS Chem. Biol.</italic>
<volume>6</volume>
<fpage>700</fpage>–<lpage>708</lpage>. <pub-id pub-id-type="doi">10.1021/cb2000296</pub-id>
<pub-id pub-id-type="pmid">21469738</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A.</given-names></name><name><surname>Tamayo</surname><given-names>P.</given-names></name><name><surname>Mootha</surname><given-names>V. K.</given-names></name><name><surname>Mukherjee</surname><given-names>S.</given-names></name><name><surname>Ebert</surname><given-names>B. L.</given-names></name><name><surname>Gillette</surname><given-names>M. A.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>102</volume>
<fpage>15545</fpage>–<lpage>15550</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id>
<pub-id pub-id-type="pmid">16199517</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tam</surname><given-names>V.</given-names></name><name><surname>Patel</surname><given-names>N.</given-names></name><name><surname>Turcotte</surname><given-names>M.</given-names></name><name><surname>Bosse</surname><given-names>Y.</given-names></name><name><surname>Pare</surname><given-names>G.</given-names></name><name><surname>Meyre</surname><given-names>D.</given-names></name></person-group> (<year>2019</year>). <article-title>Benefits and limitations of genome-wide association studies.</article-title>
<source/><italic>Nat. Rev. Genet.</italic>
<volume>20</volume>
<fpage>467</fpage>–<lpage>484</lpage>. <pub-id pub-id-type="doi">10.1038/s41576-019-0127-1</pub-id>
<pub-id pub-id-type="pmid">31068683</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>P. A.</given-names></name><name><surname>Khatami</surname><given-names>M.</given-names></name><name><surname>Baglole</surname><given-names>C. J.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Harris</surname><given-names>S. A.</given-names></name><name><surname>Moon</surname><given-names>E. Y.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Environmental immune disruptors, inflammation and cancer risk.</article-title>
<source/><italic>Carcinogenesis</italic>
<volume>36</volume>(<issue>Suppl. 1</issue>), <fpage>S232</fpage>–<lpage>S253</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/bgv038</pub-id>
<pub-id pub-id-type="pmid">26106141</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsubaki</surname><given-names>M.</given-names></name><name><surname>Takeda</surname><given-names>T.</given-names></name><name><surname>Tani</surname><given-names>T.</given-names></name><name><surname>Shimaoka</surname><given-names>H.</given-names></name><name><surname>Suzuyama</surname><given-names>N.</given-names></name><name><surname>Sakamoto</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>PKC/MEK inhibitors suppress oxaliplatin-induced neuropathy and potentiate the antitumor effects.</article-title>
<source/><italic>Int. J. Cancer</italic>
<volume>137</volume>
<fpage>243</fpage>–<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.29367</pub-id>
<pub-id pub-id-type="pmid">25430564</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsukamoto</surname><given-names>H.</given-names></name><name><surname>Mizoshita</surname><given-names>T.</given-names></name><name><surname>Katano</surname><given-names>T.</given-names></name><name><surname>Hayashi</surname><given-names>N.</given-names></name><name><surname>Ozeki</surname><given-names>K.</given-names></name><name><surname>Ebi</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Preventive effect of rebamipide on N-methyl-N’-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats.</article-title>
<source/><italic>Exp. Toxicol. Pathol.</italic>
<volume>67</volume>
<fpage>271</fpage>–<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1016/j.etp.2015.01.003</pub-id>
<pub-id pub-id-type="pmid">25617151</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Bucan</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Pathway-based approaches for analysis of genomewide association studies.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>81</volume>
<fpage>1278</fpage>–<lpage>1283</lpage>. <pub-id pub-id-type="doi">10.1086/522374</pub-id>
<pub-id pub-id-type="pmid">17966091</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weng</surname><given-names>L.</given-names></name><name><surname>Macciardi</surname><given-names>F.</given-names></name><name><surname>Subramanian</surname><given-names>A.</given-names></name><name><surname>Guffanti</surname><given-names>G.</given-names></name><name><surname>Potkin</surname><given-names>S. G.</given-names></name><name><surname>Yu</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>SNP-based pathway enrichment analysis for genome-wide association studies.</article-title>
<source/><italic>BMC Bioinformatics</italic>
<volume>12</volume>:<issue>99</issue>. <pub-id pub-id-type="doi">10.1186/1471-2105-12-99</pub-id>
<pub-id pub-id-type="pmid">21496265</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J. B.</given-names></name><name><surname>Shao</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Hu</surname><given-names>P.</given-names></name><name><surname>Shi</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>124</volume>
<fpage>2891</fpage>–<lpage>2908</lpage>. <pub-id pub-id-type="doi">10.1172/JCI70982</pub-id>
<pub-id pub-id-type="pmid">24865426</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>L.</given-names></name><name><surname>Shi</surname><given-names>W.</given-names></name><name><surname>Long</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>X.</given-names></name><name><surname>Michailidou</surname><given-names>K.</given-names></name><name><surname>Beesley</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>50</volume>
<fpage>968</fpage>–<lpage>978</lpage>. <pub-id pub-id-type="doi">10.1038/s41588-018-0132-x</pub-id>
<pub-id pub-id-type="pmid">29915430</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Powers</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>W.</given-names></name><name><surname>Hannun</surname><given-names>Y. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Substantial contribution of extrinsic risk factors to cancer development.</article-title>
<source/><italic>Nature</italic>
<volume>529</volume>
<fpage>43</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1038/nature16166</pub-id>
<pub-id pub-id-type="pmid">26675728</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Du</surname><given-names>J.</given-names></name><name><surname>Hou</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Importin beta1 mediates nuclear factor-kappaB signal transduction into the nuclei of myeloma cells and affects their proliferation and apoptosis.</article-title>
<source/><italic>Cell. Signal.</italic>
<volume>27</volume>
<fpage>851</fpage>–<lpage>859</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellsig.2015.01.013</pub-id>
<pub-id pub-id-type="pmid">25643631</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Inhibition of Karyopherin beta 1 suppresses prostate cancer growth.</article-title>
<source/><italic>Oncogene</italic>
<volume>38</volume>
<fpage>4700</fpage>–<lpage>4714</lpage>. <pub-id pub-id-type="doi">10.1038/s41388-019-0745-2</pub-id>
<pub-id pub-id-type="pmid">30742095</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zareifopoulos</surname><given-names>N.</given-names></name><name><surname>Panayiotakopoulos</surname><given-names>G.</given-names></name></person-group> (<year>2017</year>). <article-title>Neuropsychiatric effects of antimicrobial agents.</article-title>
<source/><italic>Clin. Drug Investig.</italic>
<volume>37</volume>
<fpage>423</fpage>–<lpage>437</lpage>. <pub-id pub-id-type="doi">10.1007/s40261-017-0498-z</pub-id>
<pub-id pub-id-type="pmid">28197902</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y. F.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Ni</surname><given-names>Y. H.</given-names></name><name><surname>Xu</surname><given-names>Z. M.</given-names></name></person-group> (<year>2019</year>). <article-title>Systematic elucidation of the mechanism of geraniol via network pharmacology.</article-title>
<source/><italic>Drug Des. Devel. Ther.</italic>
<volume>13</volume>
<fpage>1069</fpage>–<lpage>1075</lpage>. <pub-id pub-id-type="doi">10.2147/DDDT.S189088</pub-id>
<pub-id pub-id-type="pmid">31040644</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>He</surname><given-names>A.</given-names></name><name><surname>Zhu</surname><given-names>F.</given-names></name><name><surname>Ding</surname><given-names>M.</given-names></name><name><surname>Hao</surname><given-names>J.</given-names></name><name><surname>Fan</surname><given-names>Q.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Integrating genome-wide association study and expression quantitative trait locus study identifies multiple genes and gene sets associated with schizophrenia.</article-title>
<source/><italic>Prog. Neuropsychopharmacol. Biol. Psychiatry</italic>
<volume>81</volume>
<fpage>50</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2017.10.003</pub-id>
<pub-id pub-id-type="pmid">29024729</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>